Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001050007-17-000004
Filing Date
2017-01-26
Accepted
2017-01-26 15:22:10
Documents
48
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q nutr-123116x10q.htm 10-Q 480776
2 EXHIBIT 31.1 nutr-ex311x123116.htm EX-31.1 24497
3 EXHIBIT 32.1 nutr-ex321x123116.htm EX-32.1 10776
10 g604248.jpg GRAPHIC 15105
  Complete submission text file 0001050007-17-000004.txt   2649269

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT nutr-20161231.xml EX-101.INS 380238
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nutr-20161231.xsd EX-101.SCH 22885
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nutr-20161231_cal.xml EX-101.CAL 55536
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nutr-20161231_def.xml EX-101.DEF 91456
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nutr-20161231_lab.xml EX-101.LAB 351793
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nutr-20161231_pre.xml EX-101.PRE 182938
Mailing Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060
Business Address 1400 KEARNS BOULEVARD 2ND FLOOR PARK CITY UT 84060 4356556000
NUTRACEUTICAL INTERNATIONAL CORP (Filer) CIK: 0001050007 (see all company filings)

EIN.: 870515089 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-23731 | Film No.: 17549504
SIC: 2833 Medicinal Chemicals & Botanical Products